• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-34a 的异位表达增强了非小细胞肺癌细胞的放射敏感性,部分是通过抑制 LyGDI 信号通路实现的。

Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway.

机构信息

School of Radiation Medicine and Public Health, Soochow University, Suzhou, Jiangsu 215123, China.

出版信息

J Radiat Res. 2013 Jul 1;54(4):611-9. doi: 10.1093/jrr/rrs136. Epub 2013 Jan 24.

DOI:10.1093/jrr/rrs136
PMID:23349340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3709664/
Abstract

miR-34a is transcriptionally induced by the tumor suppressor gene p53, which is often downregulated in non-small cell lung cancer (NSCLC). To address whether the downstream signal of miR-34a is sufficient to induce apoptosis and to alter cellular radiosensitivity, a chemical synthetic miR-34a mimic was delivered into A549 and H1299 cells, with or without co-treatment of γ-irradiation. Results showed that ectopic expression of miR-34a induced dose-dependent cell growth inhibition and apoptosis in a p53-independent manner in both NSCLC cell lines. Interestingly, LyGDI was discovered as a new target gene of miR-34a, and downregulation of LyGDI promoted Rac1 activation and membrane translocation, resulting in cell apoptosis. Furthermore, restoration of miR-34a indirectly reduced cyclooxygenase-2 (COX-2) expression. Taken together, these results demonstrate that restoration of miR-34a expression enhances radiation-induced apoptosis, partly by suppressing the LyGDI signaling pathway, and miR-34a could possibly be used as a radiosensitizer for non-small cell lung cancer therapy.

摘要

miR-34a 是由肿瘤抑制基因 p53 转录诱导的,而 p53 在非小细胞肺癌(NSCLC)中经常下调。为了确定 miR-34a 的下游信号是否足以诱导细胞凋亡并改变细胞放射敏感性,将化学合成的 miR-34a 模拟物递送至 A549 和 H1299 细胞中,无论是否与 γ 射线照射共同处理。结果表明,在这两种 NSCLC 细胞系中,miR-34a 的异位表达以 p53 非依赖性方式诱导了剂量依赖性的细胞生长抑制和细胞凋亡。有趣的是,LyGDI 被发现是 miR-34a 的一个新的靶基因,下调 LyGDI 可促进 Rac1 激活和膜易位,导致细胞凋亡。此外,miR-34a 的恢复可间接降低环氧化酶-2(COX-2)的表达。总之,这些结果表明,恢复 miR-34a 的表达可增强放射诱导的细胞凋亡,部分是通过抑制 LyGDI 信号通路实现的,miR-34a 可能可作为非小细胞肺癌治疗的放射增敏剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/b9301ab8bc2c/rrs13604.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/0b369ff2ceda/rrs13601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/b6b351b0c1d5/rrs13602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/798f5bfce639/rrs13603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/b9301ab8bc2c/rrs13604.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/0b369ff2ceda/rrs13601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/b6b351b0c1d5/rrs13602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/798f5bfce639/rrs13603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c262/3709664/b9301ab8bc2c/rrs13604.jpg

相似文献

1
Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway.miR-34a 的异位表达增强了非小细胞肺癌细胞的放射敏感性,部分是通过抑制 LyGDI 信号通路实现的。
J Radiat Res. 2013 Jul 1;54(4):611-9. doi: 10.1093/jrr/rrs136. Epub 2013 Jan 24.
2
Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.瑞香素和瑞香苷通过 miR-34a 介导的 Notch-1 表达抑制诱导非小细胞肺癌细胞系的放射增敏和上皮-间充质转化(EMT)抑制。
J Biol Chem. 2013 Sep 20;288(38):27343-27357. doi: 10.1074/jbc.M113.490482. Epub 2013 Jul 31.
3
Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo.白杨素通过体内外上调 miR-34a 抑制非小细胞肺癌(NSCLC)细胞生长。
Sci Rep. 2024 Jan 29;14(1):2348. doi: 10.1038/s41598-024-52896-6.
4
miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.miR-219a-5p 通过靶向 CD164 增强非小细胞肺癌细胞的放射敏感性。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20192795.
5
MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.微小RNA-34a通过靶向转化生长因子β受体2(TGFβR2)抑制非小细胞肺癌H1299细胞系的增殖并促进其凋亡。
Tumour Biol. 2015 Apr;36(4):2481-90. doi: 10.1007/s13277-014-2861-5. Epub 2014 Dec 13.
6
Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.木樨草素通过调控 microRNA-34a-5p 抑制非小细胞肺癌细胞的肿瘤发生并诱导其凋亡。
Int J Mol Sci. 2018 Feb 2;19(2):447. doi: 10.3390/ijms19020447.
7
Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.miR-34a 诱导非小细胞肺癌细胞上皮-间充质转化及其对 p53 的影响
Biomolecules. 2021 Dec 9;11(12):1853. doi: 10.3390/biom11121853.
8
MicroRNA expression and clinical outcome of small cell lung cancer.微小 RNA 表达与小细胞肺癌的临床结局。
PLoS One. 2011;6(6):e21300. doi: 10.1371/journal.pone.0021300. Epub 2011 Jun 22.
9
MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A.miR-365 通过靶向 CDC25A 增强非小细胞肺癌细胞的放射敏感性。
Biochem Biophys Res Commun. 2019 Apr 30;512(2):392-398. doi: 10.1016/j.bbrc.2019.03.082. Epub 2019 Mar 20.
10
LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.长链非编码 RNA SBF2-AS1 通过调节 microRNA-302a/MBNL3 轴影响非小细胞肺癌的放射敏感性。
Cell Cycle. 2020 Feb;19(3):300-316. doi: 10.1080/15384101.2019.1708016. Epub 2020 Jan 13.

引用本文的文献

1
Ectopic expression of miR-34a/-328 sensitizes breast cancer stem cells to gamma rays/doxorubicin by BCL2/ABCG2 targeting.通过靶向BCL2/ABCG2,miR-34a/-328的异位表达使乳腺癌干细胞对γ射线/阿霉素敏感。
Mol Biol Rep. 2025 May 22;52(1):490. doi: 10.1007/s11033-025-10581-5.
2
MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance.间充质干细胞衍生的细胞外囊泡:用于克服癌症治疗耐药性的精准miRNA递送
Regen Ther. 2025 Apr 1;29:303-318. doi: 10.1016/j.reth.2025.03.006. eCollection 2025 Jun.
3
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.

本文引用的文献

1
miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.miR-34a 和 miR-15a/16 在非小细胞肺癌中协同调控并依赖 Rb 共同控制细胞周期进程。
Mol Cancer. 2011 May 16;10:55. doi: 10.1186/1476-4598-10-55.
2
Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.通过联合脉冲 SILAC 和微阵列分析对 miR-34a 诱导的蛋白质和 mRNA 表达变化进行全基因组特征分析。
Mol Cell Proteomics. 2011 Aug;10(8):M111.010462. doi: 10.1074/mcp.M111.010462. Epub 2011 May 12.
3
基于外泌体的微小RNA递送:用间充质干细胞改变癌症治疗
Regen Ther. 2025 Feb 13;28:558-572. doi: 10.1016/j.reth.2025.01.019. eCollection 2025 Mar.
4
Hybrid deep learning technique for COX-2 inhibition bioactivity detection against breast cancer disease.用于检测针对乳腺癌疾病的COX-2抑制生物活性的混合深度学习技术
Biomed Eng Lett. 2024 Apr 10;14(4):631-647. doi: 10.1007/s13534-024-00355-6. eCollection 2024 Jul.
5
The microRNA-34 Family and Its Functional Role in Lung Cancer.miRNA-34 家族及其在肺癌中的功能作用。
Am J Clin Oncol. 2024 Sep 1;47(9):448-457. doi: 10.1097/COC.0000000000001106. Epub 2024 May 3.
6
Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression.利用微小RNA表达组合模型改善临床肿瘤样本放疗反应预测
Front Genet. 2022 Nov 22;13:1069112. doi: 10.3389/fgene.2022.1069112. eCollection 2022.
7
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.细胞周期相关的微小RNA作为肺癌治疗的靶点和疗法
Heliyon. 2022 Oct 13;8(10):e11081. doi: 10.1016/j.heliyon.2022.e11081. eCollection 2022 Oct.
8
CARD9 Mediates Pancreatic Islet Beta-Cell Dysfunction Under the Duress of Hyperglycemic Stress.CARD9 介导高血糖应激下胰岛β细胞功能障碍。
Cell Physiol Biochem. 2022 Apr 1;56(2):120-137. doi: 10.33594/000000508.
9
Rho GTPases in cancer radiotherapy and metastasis.Rho GTP酶在癌症放射治疗与转移中的作用
Cancer Metastasis Rev. 2020 Dec;39(4):1245-1262. doi: 10.1007/s10555-020-09923-5. Epub 2020 Aug 8.
10
Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications.miR-34a在癌症中的多功能作用:一篇重点关注头颈部鳞状细胞癌和甲状腺癌并具有临床意义的综述
Diagnostics (Basel). 2020 Aug 5;10(8):563. doi: 10.3390/diagnostics10080563.
In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer.
纳米脂质体顺铂作为放射增敏剂的体内外研究。
Int J Nanomedicine. 2011;6:437-44. doi: 10.2147/IJN.S15997. Epub 2011 Feb 21.
4
miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1.miR-9 和 let-7g 通过抑制 NFκB1 增强对电离辐射的敏感性。
Exp Mol Med. 2011 May 31;43(5):298-304. doi: 10.3858/emm.2011.43.5.031.
5
miRNA-34a is associated with docetaxel resistance in human breast cancer cells.miRNA-34a 与人类乳腺癌细胞对多西紫杉醇的耐药性有关。
Breast Cancer Res Treat. 2012 Jan;131(2):445-54. doi: 10.1007/s10549-011-1424-3. Epub 2011 Mar 12.
6
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.微小 RNA miR-34a 通过直接抑制 CD44 抑制前列腺癌干细胞和转移。
Nat Med. 2011 Feb;17(2):211-5. doi: 10.1038/nm.2284. Epub 2011 Jan 16.
7
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.miR-34a 通过调节髓母细胞瘤中的 MAGE-A 和 p53 赋予化疗敏感性。
Neuro Oncol. 2011 Feb;13(2):165-75. doi: 10.1093/neuonc/noq179. Epub 2010 Dec 22.
8
Up-regulation of RhoGDI2 in human breast cancer and its prognostic implications.RhoGDI2 在人乳腺癌中的上调及其预后意义。
Cancer Res Treat. 2010 Sep;42(3):151-6. doi: 10.4143/crt.2010.42.3.151. Epub 2010 Sep 30.
9
Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora A.人乳头瘤病毒 16 E6 增加了 p53 突变型宫颈癌细胞的放射敏感性,与 aurora A 的上调有关。
Int J Radiat Biol. 2010 Sep;86(9):769-79. doi: 10.3109/09553002.2010.484477.
10
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.基于抑癌 microRNA-34 开发肺癌治疗方法。
Cancer Res. 2010 Jul 15;70(14):5923-30. doi: 10.1158/0008-5472.CAN-10-0655. Epub 2010 Jun 22.